a国产,中文字幕久久波多野结衣AV,欧美粗大猛烈老熟妇,女人av天堂

(dng)ǰλã > > r(nng)I(y)ʿՓ >

MȥøƄOxamflatiniw(x)¡̥wl(f)ʵӰ

l(f)rg2018-05-07 07:35

  x}i + w(x)ֲ Ar(nng)I(y)W(xu)2016격ʿՓ


ժҪw(x)ֲg(sh)(SCNT)ָһֻw(x)cȥ˵ĸ(x)ںγһؘ(gu)̥,l(f)a(chn)cw(x)zһµĿ¡ļg(sh)1996Qԁ,оˆTw(x)ֲg(sh)ѽ(jng)ɹ¡ܶಸ,С؈ţiMԓg(sh)ѽ(jng)l(f)չ˽20,w(x)¡Ч߀Ǻܵ(s1%-5%),w(x)¡F(xin)һЩı:F(xin)̥ʵ̥a(chn)ʸ,¡w^󲢰SNٰl(f)ȱݵİY,ҲQ̥CϰYͮĿ¡ֳҺͶ,f¡Įɮı^zɵĶz|(zh)ĸ׃ĿǰоձJ(rn)w(x)ֲЧʵ͵ԭĸ(x)w(x)˲ȫ򮐳ؾ̌(do)µġw(x)ֲg(sh)һ헺Б(yng)ǰļg(sh),HԎ҂˽w(x)ؾ̵ęC(j),ͬr˵ֲt(y)W(xu)оSCNTg(sh)c݋g(sh)Y(ji),a(chn)D(zhun)i,翹i,(yu)Ʒ|(zh)Ԡi,h(hun)Ѻiȡbw(x)ֲҪđ(yng)ÃrֵԼ^͵Ŀ¡Ч,о@iĿ¡Ч@һ}չ_,w¡Чʵͬr,ؾ̵ķәC(j)M(jn)M(jn)һ̽,ҪY(ji):1.ͨ^A(y)(sh)(yn)҂l(f)F(xin),iB(yng)(PZM-3)һĽMȥøƄOxamflatin,@iw¡̥γʡȻ҂(yu)Oxamflatin̎l(ͬ̎Ⱥͳm(x)rg),l(f)F(xin)1MĽMȥøƄOxamflatinؘ̎(gu)̥15h,@w߰l(f)(δ̎Mvs.̎M;10.3%vs.25.5%;p0.05)2.1MOxamflatin̎i¡̥15h@ؘ(gu)̥ԭ˕rڿȥøĻ,˿¡̥ԭ,2(x)4(x)r,ĽMH3K9H4K5ˮƽ҂zyķN͵iĽMȥø(HDAC1-11,Sirt1,2)MIIĸ(x)i̥wS(x)еmRNA_(d)ˮƽ,Y(ji)l(f)F(xin),HDAC123MIIĸ(x)_(d)̥wS(x),ͬrҲ͵ĽMȥø_(d)ҪOxamflatin̎@ؘ(gu)̥ԭ˕rHDAC1ı_(d),ϽOxamflatin̎錧(do)ĸĽMH3K9H4K5ˮƽ3.҂ͬrzyһǽMצ-tubulin׵ˮƽ,l(f)F(xin)1MOxamflatin̎15h@iؘ(gu)̥gwͼNw̥ǰɂнzѼ(x)^-tubulinˮƽ,@ͨ^HDAC6ı_(d)錧(do)ġ4.ͨ^ɹⶨPCR҂l(f)F(xin)DNA׻D(zhun)ø1(DNMT1)iMIIĸ(x)ռ(do),ı_(d)ͬԴDNMT2,DNMT3a3bı_(d)Ҫ߳50౶ͨ^ߟɹȾɫ҂zyi¡̥2(x)4(x)rڿ5-mC5-hmCˮƽ,Y(ji),iSCNT̥2(x)4(x)r,5-mC5-hmCˮƽu1MOxamflatin̎iؘ(gu)̥15h@ؽi¡̥2(x)rڿDNA׻ˮƽ,ͬrDNMT12(x)rڵı_(d)5.1MOxamflatin̎iؘ(gu)̥15h@˶ܻPOU5F1i¡̥Aεı_(d),@ͨ^POU5F1Ӆ^(q)DNA׻ˮƽ,Oxamflatin̎]и׃il(wi)DNAеļ׻ˮƽ6.̈́Oxamflatin̎]i̥wS(x)LB(ti),Oxamflatin̎ͬӌ(do)i̥wS(x)^ߵĽMH3K9H4K5ͷǽMצ-tubulinˮƽ,ͬrOxamflatin̎һ̶Ͻi̥wS(x)DNA׻ˮƽOxamflatinA(y)̎i̥wS(x)˹w(x),]ؘ(gu)̥w߰l(f)@,Oxamflatinͨ^ƹw(x)MȥøĻ,ͨ^ĸ(x)MȥøĻ,Ķ(do)^ߵiw(x)¡Чͨ^о҂MȥøƄOxamflatin߿¡ЧʵķәC(j)˳J(rn)R,@҂õw(x)ֲؾ̙C(j)һąrֵ
[Abstract]:Somatic cell nuclear transplantation (SCNT) is a technique for the fusion of a differentiated somatic cell with a nucleated oocyte to form a reconstructed embryo and develop a technique to clone offspring that is consistent with the genetic background of donor cells. Since the birth of Dolly sheep in 1996, researchers have successfully cloned a lot of lactation by the technique of body cell nucleus transplantation. The offspring of animals, such as mice, dogs, cats, cattle, pigs and so on. But although the technology has been developed for nearly 20 years, the efficiency of somatic cell cloning is still very low (mammalian about 1%-5%), and the cloned progeny of somatic cells often appear some abnormal phenotypes: low embryo implantation rate, high fetal abortion rate, too large cloned animals with various organs and various organs. The symptoms of developmental defects are also known as large fetal syndrome. However, the abnormal phenotype of cloned animals can reproduce normally and the later representative type is normal, indicating that the abnormal phenotype of the cloned animal is caused by abnormal epigenetic modification, not due to the change of genetic material. The low reason is that the oocyte is reprogrammed with incomplete or abnormal somatic cell nuclei. Somatic cell nuclear transplantation is a promising technology. It can not only help us understand the mechanism of reprogramming of somatic cells, but also can be used in the combination of.SCNT technology and gene editing technology in human organ transplantation. In order to produce transgenic pigs, such as disease resistant pigs, pigs with good meat quality, environment friendly pigs and so on. In view of the important application value of somatic cell nuclear transplantation and its low cloning efficiency, this study focuses on how to improve the cloning efficiency of pigs, while improving the efficiency of cloning in vitro, the reprogrammed molecular machine The main results are as follows: 1. through pre experiment, we found that adding a certain dose of histone deacetylase inhibitor Oxamflatin to the porcine zygote medium (PZM-3) could significantly increase the rate of the blastocyst formation of the porcine in vitro cloned embryo. Then we optimized the treatment conditions of Oxamflatin (different treatments). Concentration and duration), it was found that the reconfigurable embryo 15h was treated with 1 M histone deacetylase inhibitor Oxamflatin, which significantly increased the development rate of the blastocyst in vitro (the untreated group vs. treatment group; 10.3%vs.25.5%; P0.05).2. with 1 micron M in the Oxamflatin treatment Zhu Kelong embryo 15h significantly reduced the total deb of the reconstructive embryo during the prokaryotic period. The activity of acylase increased the acetylation level of the total histone H3K9 and H4K5 in the prokaryotic, 2 and 4 cell stages of the cloned embryo. We detected the mRNA expression level of the histone deacetylase (including HDAC1-11, and Sirt1,2) in four types of pig's histone (including HDAC1-11, and Sirt1,2) in MII oocytes and pig fetal fibroblasts. The results were found, HDAC1,2 The relative expression of and 3 in MII oocytes was higher than that of fetal fibroblasts, and the higher.Oxamflatin treatment compared with other types of histone deacetylase expression significantly reduced the expression of HDAC1 in the prokaryotic stage of restructured embryos, partly explaining the high acetylation of histone H3K9 and H4K5 level.3. mediated by Oxamflatin treatment. We also detected the acetylation level of a non histone alpha -tubulin protein. It was found that the use of 1 M Oxamflatin to treat 15h significantly improved the intermediate of porcine reconstituted embryos and the level of acetylated alpha -tubulin during the cycle of the first two mitotic cells after the activation of the embryo, which may be mediated by the inhibition of the expression of HDAC6. .4. guided by fluorescence quantitative PCR we found that DNA methyltransferase 1 (DNMT1) was dominant in porcine MII oocytes, and its expression was more than 50 times higher than that of its homologous gene DNMT2, DNMT3a and 3b. We detected the total 5-mC and 5-hmC levels of porcine cloned embryo fetal in 2 and 4 cells by immunofluorescence staining. The results showed that the total 5-mC and 5-hmC levels of the pig SCNT embryos decreased gradually from 2 to 4 cells. The total DNA methylation level in the 2 cell period of pig cloned embryos was significantly reduced by the Oxamflatin treatment with 1 u M Oxamflatin, and the Oxamflatin treatment of DNMT1 in the 2 cell period of.5. with 1 micron M Oxamflatin treatment of the porcine reconstructed embryo 15h was reduced. The expression of the multipotential gene POU5F1 in the blastocyst stage of the porcine cloned embryo could be significantly increased by reducing the level of DNA methylation in the POU5F1 promoter region. However, Oxamflatin treatment did not alter the methylation level of the DNA sequence of the pig satellite.6. and the low dose of Oxamflatin did not inhibit the growth of porcine fetal fibroblasts. State, Oxamflatin treatment also leads to higher histone H3K9, H4K5 and the level of acetylation of non histone alpha -tubulin in pig fetal fibroblasts, while Oxamflatin treatment reduces the total DNA methylation level in pig fetal fibroblasts to some extent. However, pig fetal fibroblasts treated with Oxamflatin are used as nuclear donor cells. Somatic cells do not increase the development rate of blastocysts in vitro of reconstructed embryos. This indicates that Oxamflatin is not by inhibiting the activity of the donor cell histone deacetylase, but by inhibiting the activity of the oocyte histone deacetylase, which leads to the higher cloning efficiency of the pig somatic cells. The molecular mechanism of the acylase inhibitor Oxamflatin to improve the cloning efficiency has a preliminary understanding, which is of certain reference value for our better understanding of the mechanism of reprogramming of somatic cell nuclear transfer in the future.

W(xu)λλAr(nng)I(y)W(xu)
W(xu)λeʿ
W(xu)λݡ2016
̖S828

īI(xin)

P(gun)ڿՓ ǰ5l

1 w;T_;;Q;;;S;;;˵ǿ;;;w(x)LOHͻ׃Ƃ1,3-ǻD(zhun)ø(GGTA1)ȱʧָɽСi[J];Ft(y)W(xu);201304

2 Rʢ;;t;;;_d;S;R˟;;VRСi¡ߵĘ(gu)ֲ̥[J];W(xu)s־;200806

3 A;܊;;ュ;בcȻ;;;;RM;Oˬ;;;;w(x)ֲa(chn)Gɫɹ⵰D(zhun)i[J];ƌW(xu)ͨ;200805

4 A;ュ;;;܊;;;RM;בcȻ;Oˬ;;;;w(x)ֲ¡i:B(yng)Һĸ(x)켰̥l(f)Ӱ[J];ЇƌW(xu)(C݋:ƌW(xu));200706

5 ˵ǿ;\(yn);O;;;;־;N(yn)ƽ;dz;;;B(yng)̥¡Сi(Sus Scrofa)[J];ƌW(xu)ͨ;200604

P(gun)ʿW(xu)λՓ ǰ1l

1 \(yn);w(x)ֲg(sh)a(chn)i¡̥о[D];Їr(nng)I(y)W(xu);2005



ľ̖1855989

Yd
Փİl(f)

朽ӣhttp://www.wukwdryxk.cn/shoufeilunwen/nykjbs/1855989.html


Copyright(c)ՓՓľW(wng)All Rights Reserved | W(wng)վ؈D |

(qun)YÑ889e5***ṩվHժҪĿҪhՈE-mail]bigeng88@qq.com
þ޾Ʒվ| žžAV| | Ʒһ| ƷӰԺպ~ŷһĻ| 55󶫱Ůžž໽| Ʒþþþþùţţ| ٸxx| ޾ƷĻ91| ͵v͵v޸| Ů@TubeumTV| ƷһʽӰ| ŷƵ| ޳aƬ߹ۿ| ޹Ʒþ | ޹ľƷѾþ| ŮŮٺϻοAVڵ| Ӱӵɫҳ| | һ߹ۿƵ| Ū| ƷëƬ| ߹ۿվ| AVۺɫһ| 69޾Ʒþר| Ʒ㽶߹ۿ | Ұⱻˬ׽| 봺ɫavר| AVۺ뾫Ʒ| avպaɫͷ| ŮڵƵ| | av| ҹӰ| þcom| ŷһ| ձؼؼŷɫۺ| ձhd| ʦɫ˿౻귭av| 㽶97Ƶva| ƷƷŮ߹ۿ|